Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Time to reinvent the launch

Posted 21 December 2020 PM

Pharma companies that use traditional models to launch new products in 2021 will "struggle" according to a report warning the industry to embrace a fresh approach that is "digital, local and personalised" in order to succeed.

The fall-out from COVID-19 impacted heavily on pharmaceutical launches in 2020 with a new McKinsey & Company report revealing every pharmaceutical product launch between February and August this year was disrupted by the pandemic through delays, lost revenues or both.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Biden and the MA agreement
'Global decisions' will influence ongoing negotiations
Special Report
PBAC March agenda
Every major and minor sub sorted by indication
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas